NFKB1 and diffuse large B-cell lymphoma: A similar correlation was found in GCB DLBCL patients with wild-type TP53, however p50 expression in GBC DLBCL patients with TP53 mutants was associated with a significantly improved outcome, as well as reduced expression of Bcl-2, Myc and p53 [65].